NVO vs AMGN: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Amgen Inc in 2026
NVO
Novo Nordisk A S
$45.51
AMGN
Amgen Inc
$336.48
Key Metrics Comparison
| Metric | NVO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $197.39B | $181.37B | NVO |
| P/E Ratio | 10.43 | 23.37 | NVO |
| EPS (TTM) | $4.27 | $14.38 | AMGN |
| Revenue Growth | 0.2% | 0.1% | NVO |
| Gross Margin | 83.2% | 71.4% | NVO |
Analyze NVO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or AMGN a better investment?
Comparing NVO and AMGN: Novo Nordisk A S has a market cap of $197.39B while Amgen Inc has $181.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and AMGN?
NVO (Novo Nordisk A S) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or AMGN?
Based on P/E ratios, NVO trades at a lower multiple (10.4x vs 23.4x).
Which is growing faster: NVO or AMGN?
NVO has higher revenue growth at 0.2% vs 0.1% for AMGN.
Which company is more profitable: NVO or AMGN?
Novo Nordisk A S (NVO) has higher gross margins at 83.2% compared to 71.4% for AMGN.
Which is the larger company: NVO or AMGN?
Novo Nordisk A S (NVO) is larger with a market cap of $197.39B compared to $181.37B for AMGN.
Should I buy NVO or AMGN in 2026?
Both NVO and AMGN have investment merit. NVO trades at $45.51 while AMGN trades at $336.48. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and AMGN stock?
Key differences: Market Cap ($197.39B vs $181.37B), P/E Ratio (10.4x vs 23.4x), Revenue Growth (0.2% vs 0.1%), Gross Margin (83.2% vs 71.4%).